Acquisition of Soleno Therapeutics, Inc. - Summarizes Preliminary Consideration Transferred (Details) - Soleno Therapeutics, Inc. $ in Millions |
May 18, 2026
USD ($)
|
|---|---|
| Business Combination [Line Items] | |
| Total preliminary consideration transferred | $ 2,829.9 |
| Holders of Soleno Equity Awards | |
| Business Combination [Line Items] | |
| Cash paid to Soleno stockholders | 2,762.5 |
| Holders of Soleno Common Stock | |
| Business Combination [Line Items] | |
| Cash paid to Soleno stockholders | $ 67.4 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|